Simplex Trading’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-19,351
| Closed | -$12K | – | 9894 |
|
|
2024
Q2 | $12K | Buy |
+19,351
| New | +$12K | ﹤0.01% | 7337 |
|
|
2023
Q3 | – | Sell |
-3,334
| Closed | -$4.08K | – | 10133 |
|
|
2023
Q2 | $10K | Buy |
3,334
+3,305
| +11,397% | +$9.99K | ﹤0.01% | 7455 |
|
|
2023
Q1 | $0 | Sell |
29
-2,113
| -99% | -$29.9K | ﹤0.01% | 10406 |
|
|
2022
Q4 | $25K | Sell |
2,142
-77
| -3% | -$1.36K | ﹤0.01% | 6673 |
|
|
2022
Q3 | $46K | Buy |
2,219
+797
| +56% | +$21.5K | ﹤0.01% | 6573 |
|
|
2022
Q2 | $34K | Buy |
1,422
+875
| +160% | +$29.8K | ﹤0.01% | 7001 |
|
|
2022
Q1 | $27K | Sell |
547
-601
| -52% | -$29.7K | ﹤0.01% | 7917 |
|
|
2021
Q4 | $80K | Buy |
1,148
+203
| +21% | +$17.1K | ﹤0.01% | 6590 |
|
|
2021
Q3 | $97K | Hold |
945
| – | – | ﹤0.01% | 6658 |
|
|
2021
Q2 | $94K | Buy |
945
+35
| +4% | +$3.41K | ﹤0.01% | 6829 |
|
|
2021
Q1 | $84K | Sell |
910
-867
| -49% | -$87.9K | ﹤0.01% | 5980 |
|
|
2020
Q4 | $146K | Sell |
1,777
-695
| -28% | -$59.3K | ﹤0.01% | 5014 |
|
|
2020
Q3 | $212K | Buy |
2,472
+2,469
| +82,300% | +$288K | ﹤0.01% | 4038 |
|
|
2020
Q2 | $0 | Buy |
+3
| New | +$165 | ﹤0.01% | 8553 |
|
|
2020
Q1 | – | Sell |
-9
| Closed | -$350 | – | 8444 |
|
|
2019
Q4 | $0 | Buy |
+9
| New | +$197 | ﹤0.01% | 8132 |
|
|
2019
Q2 | – | Sell |
-3
| Closed | – | – | 7964 |
|
|
2019
Q1 | $0 | Buy |
+3
| New | +$162 | ﹤0.01% | 8045 |
|
|
2018
Q4 | – | Sell |
-35
| Closed | -$2K | – | 7990 |
|
|
2018
Q3 | $2K | Buy |
35
+17
| +94% | +$1.12K | ﹤0.01% | 7113 |
|
|
2018
Q2 | $1K | Buy |
+18
| New | +$1.74K | ﹤0.01% | 7221 |
|
Simplex Trading's VBIV Position: Q3 2024 in Review
Simplex Trading sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2024, closing a stake of 19,351 shares — an estimated $12K sold.
Simplex Trading first reported a position in VBIV in Q2 2018 and held it in 18 quarters. The position peaked at $212K in Q3 2020. 1 fund tracked by Wall St. Rank holds VBIV as of Q3 2024.
- Simplex Trading reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2024 after selling out during the quarter.
- Simplex Trading sold 19,351 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2024, an estimated $12K.
- Simplex Trading first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2018 and held it in 18 quarters.
- Simplex Trading's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $212K in Q3 2020.
- 1 fund tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2024.
Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.